These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25723790)

  • 1. Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model.
    Polster CS; Wu SJ; Gueorguieva I; Sperry DC
    Mol Pharm; 2015 Apr; 12(4):1131-40. PubMed ID: 25723790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative bioavailability of three different solid forms of PNU-141659 as determined with the artificial stomach-duodenum model.
    Carino SR; Sperry DC; Hawley M
    J Pharm Sci; 2010 Sep; 99(9):3923-30. PubMed ID: 20564336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of an Artificial Stomach-Duodenum Reduced Gastric pH Dog Model for Formulation Principle Assessment and Mechanistic Performance Understanding.
    Lee CM; Luner PE; Locke K; Briggs K
    J Pharm Sci; 2017 Aug; 106(8):1987-1997. PubMed ID: 28238897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
    Mitra A; Fadda HM
    Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
    Pereira JM; Mejia-Ariza R; Ilevbare GA; McGettigan HE; Sriranganathan N; Taylor LS; Davis RM; Edgar KJ
    Mol Pharm; 2013 Dec; 10(12):4640-53. PubMed ID: 24116899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gastric pH on the pharmacokinetics of a BCS class II compound in dogs: utilization of an artificial stomach and duodenum dissolution model and GastroPlus,™ simulations to predict absorption.
    Bhattachar SN; Perkins EJ; Tan JS; Burns LJ
    J Pharm Sci; 2011 Nov; 100(11):4756-65. PubMed ID: 21681753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
    Xie T; Gao W; Taylor LS
    Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically Based Absorption Modeling for Amorphous Solid Dispersion Formulations.
    Mitra A; Zhu W; Kesisoglou F
    Mol Pharm; 2016 Sep; 13(9):3206-15. PubMed ID: 27442959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of artificial stomach-duodenum model for investigation of dosing fluid effect on clinical trial variability.
    Polster CS; Atassi F; Wu SJ; Sperry DC
    Mol Pharm; 2010 Oct; 7(5):1533-8. PubMed ID: 20669969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.
    Tanaka Y; Tay E; Nguyen TH; Porter CJH
    Pharm Res; 2020 Feb; 37(3):47. PubMed ID: 32016597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor.
    Cui Y; Chiang PC; Choo EF; Boggs J; Rudolph J; Grina J; Wenglowsky S; Ran Y
    Int J Pharm; 2013 Sep; 454(1):241-8. PubMed ID: 23834830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM; Wendelboe J; Holm R; Rades T
    Eur J Pharm Biopharm; 2018 Sep; 130():290-295. PubMed ID: 30064702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Investigation of Oral Exposure Variability and Formulation Strategy: A Case Study of PI3Kδ Inhibitor and Physiologically Based Pharmacokinetic Modeling in Beagle Dogs.
    Chiang PC; Pang J; Liu J; Salphati L
    J Pharm Sci; 2018 Jan; 107(1):466-475. PubMed ID: 28652157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
    Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
    Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.